A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT05974293 · WITHDRAWN

Trial details

NCT number: NCT05974293
Sponsor: Michael, Levy M.D.,Ph.D.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

NMO Spectrum Disorder Spasticity, Muscle

Start date: 2026-12-31
Primary completion: 2027-04-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.